Last Patient Out (LPO) from the Phase II study of linaprazan glurate
On September 1st, we had LPO – Last Patient Out, from the Phase II study of linaprazan glurate. The study includes a total of 228 patients.
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
Gösta Hiller - A driven leader who wants to build smart teams and see people grow together
Gösta has extensive experience in leadership positions that will come in handy as Cinclus now prepares for the next step.
Read more
Cinclus Pharma at the ABGSC – Life Science Summit
Cinclus Pharma participated in the ABGSC Life Science Summit, where CEO Christer Ahlberg presented the recent company updates and the development of linaprazan glurate.
Read more